David C. Lye
Experienced in Necrotizing Fasciitis

David C. Lye

12 Science Drive 2, 
Singapore, SG 
Experienced in Necrotizing Fasciitis
12 Science Drive 2, 
Singapore, SG 
OverviewLocationsClinical Research

Overview

David Lye practices in Singapore, Singapore. Mr. Lye is rated as an Experienced expert by MediFind in the treatment of Necrotizing Fasciitis. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 350 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Necrotizing Fasciitis.

Gender
Male

Locations

12 Science Drive 2, Singapore, 117549, Singapore

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Heterologous Prime-boost-boost Vaccine Combinations for Long-term Humoral and Cellular Immunity Against COVID-19
Heterologous Prime-boost-boost Vaccine Combinations for Long-term Humoral and Cellular Immunity Against COVID-19
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Biological
Study Phase: Phase 4
CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial
CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial
Enrollment Status: Terminated
Publish Date: December 19, 2018
Intervention Type: Drug
Study Phase: Phase 3
Randomized Controlled Trial of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to Ceftriaxone Non-susceptible E. Coli and Klebsiella Species.
Randomized Controlled Trial of Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Due to Ceftriaxone Non-susceptible E. Coli and Klebsiella Species.
Enrollment Status: Terminated
Publish Date: November 27, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

350 Total Publications

Circulating Biomarkers Predict Platelet Recovery in Adult Dengue Patients with Thrombocytopenia Receiving Prophylactic Platelet Transfusion.
Circulating Biomarkers Predict Platelet Recovery in Adult Dengue Patients with Thrombocytopenia Receiving Prophylactic Platelet Transfusion.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lye's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile